Products for Research Use Only

Vigabatrin

CAT: 0931-T0128-02Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T0128-02Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
60643-86-9
Target
ABC Transporter, GABA Receptor
Related Pathways
Neuroscience, Membrane transporter/Ion channel
Purity
0.9988
Bioactivity
Vigabatrin (Sabril), an analogue of gamma-aminobutyric acid, is an irreversible inhibitor of 4-aminobutyrate Transaminase responsible for the catabolism of γ-aminobutyric acid.
Smiles
NC(CCC(O)=O)C=C
Molecular Formula
C6H11NO2
Molecular Weight
129.16
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Chemical Information

Vigabatrin

Vigabatrin is a gamma-amino acid having a gamma-vinyl GABA structure. It is an irreversible inhibitor of gamma-aminobutyric 664 acid transaminase. It has a role as an anticonvulsant and an EC 2.6.1.19 (4-aminobutyrate--2-oxoglutarate transaminase) inhibitor.

CAS Number60643-86-9
PubChem CID5665
IUPAC Name4-aminohex-5-enoic acid
Molecular FormulaC6H11NO2
Molecular Weight129.16
XLogP-2.2
Topological Polar Surface Area63.3
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count4
Heavy Atom Count9
Formal Charge0
Complexity112
SMILES
C=CC(CCC(=O)O)N
InChI
InChI=1S/C6H11NO2/c1-2-5(7)3-4-6(8)9/h2,5H,1,3-4,7H2,(H,8,9)
InChIKey
PJDFLNIOAUIZSL-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of Vigabatrin
CAS: 60643-86-9
CID: 5665
Formula: C6H11NO2
MW: 129.16
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight129.16
XLogP3-2.2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count4
Exact Mass129.078978594
Monoisotopic Mass129.078978594
Topological Polar Surface Area63.3 Ų
Heavy Atom Count9
Formal Charge0
Complexity112
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Alternative Products